No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr5:74614000-74621400 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
2 |
chr5:74614600-74617400 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
3 |
chr5:74614800-74617200 |
Flanking Active TSS |
Primary neutrophils fromperipheralblood |
blood
|
4 |
chr5:74614800-74617400 |
Flanking Active TSS |
Monocytes-CD14+_RO01746 |
blood
|
5 |
chr5:74614800-74617600 |
Enhancers |
Placenta Amnion |
Placenta Amnion
|
6 |
chr5:74615000-74617400 |
Enhancers |
HepG2 |
liver
|
7 |
chr5:74615400-74617400 |
Enhancers |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
8 |
chr5:74615600-74617600 |
Enhancers |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
9 |
chr5:74615600-74617600 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
10 |
chr5:74615600-74618200 |
Enhancers |
HUES6 Cell Line |
embryonic stem cell
|
11 |
chr5:74615800-74617000 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
12 |
chr5:74615800-74617000 |
Enhancers |
HMEC |
breast
|
13 |
chr5:74615800-74617200 |
Enhancers |
H1 BMP4 Derived Mesendoderm Cultured Cells |
ES cell derived
|
14 |
chr5:74615800-74617400 |
Enhancers |
iPS-15b Cell Line |
embryonic stem cell
|
15 |
chr5:74615800-74617400 |
Flanking Active TSS |
A549 |
lung
|
16 |
chr5:74615800-74618400 |
Enhancers |
Fetal Adrenal Gland |
Adrenal Gland
|
17 |
chr5:74616000-74617000 |
Enhancers |
iPS-20b Cell Line |
embryonic stem cell
|
18 |
chr5:74616000-74617000 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
19 |
chr5:74616000-74617200 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
20 |
chr5:74616000-74617400 |
Enhancers |
Bone Marrow Derived Cultured Mesenchymal Stem Cells |
Bone marrow
|
21 |
chr5:74616000-74618400 |
Enhancers |
H1 Cell Line |
embryonic stem cell
|
22 |
chr5:74616200-74617000 |
Enhancers |
NHEK |
skin
|
23 |
chr5:74616200-74617400 |
Enhancers |
NHLF |
lung
|
24 |
chr5:74616200-74617600 |
Enhancers |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
25 |
chr5:74616200-74617600 |
Enhancers |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
26 |
chr5:74616200-74617800 |
Enhancers |
HUES48 Cell Line |
embryonic stem cell
|
27 |
chr5:74616200-74617800 |
Enhancers |
Muscle Satellite Cultured Cells |
--
|
28 |
chr5:74616200-74617800 |
Flanking Active TSS |
Hela-S3 |
cervix
|
29 |
chr5:74616400-74617400 |
Enhancers |
HSMM |
muscle
|
30 |
chr5:74616400-74617600 |
Enhancers |
K562 |
blood
|
31 |
chr5:74616400-74617600 |
Enhancers |
NHDF-Ad |
bronchial
|
32 |
chr5:74616600-74617000 |
Weak transcription |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
33 |
chr5:74616600-74617000 |
Enhancers |
H9 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
34 |
chr5:74616600-74617400 |
Enhancers |
H9 Cell Line |
embryonic stem cell
|
35 |
chr5:74616600-74617400 |
Enhancers |
H9 Derived Neuron Cultured Cells |
ES cell derived
|
36 |
chr5:74616600-74617400 |
Enhancers |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
37 |
chr5:74616600-74617400 |
Flanking Active TSS |
NH-A |
brain
|
38 |
chr5:74616600-74617600 |
Enhancers |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
39 |
chr5:74616600-74619000 |
Enhancers |
iPS-18 Cell Line |
embryonic stem cell
|
40 |
chr5:74616800-74617000 |
Enhancers |
ES-I3 Cell Line |
embryonic stem cell
|
41 |
chr5:74616800-74617000 |
Enhancers |
HUES64 Cell Line |
embryonic stem cell
|
42 |
chr5:74616800-74617000 |
Enhancers |
HSMMtube |
muscle
|
43 |
chr5:74616800-74617200 |
Enhancers |
H1 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
44 |
chr5:74616800-74617200 |
Enhancers |
Foreskin Melanocyte Primary Cells skin01 |
Skin
|
45 |
chr5:74616800-74617200 |
Enhancers |
Osteobl |
bone
|
46 |
chr5:74616800-74617600 |
Enhancers |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
47 |
chr5:74616800-74617600 |
Enhancers |
ES-UCSF4 Cell Line |
embryonic stem cell
|